Development, maintenance and disruption of the blood-brain barrier - Wikidata - awgldk - TriplyDB

Development, maintenance and disruption of the blood-brain barrier

Development, maintenance and disruption of the blood-brain barrier

http://www.wikidata.org/entity/Q26829668

about

Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair Microbial view of central nervous system autoimmunity The Wnt7's Tale: A story of an orphan who finds her tie to a famous family Mechanical and Biological Interactions of Implants with the Brain and Their Impact on Implant Design Fetal Alcohol Spectrum Disorders: An Overview from the Glia Perspective Toward more predictive genetic mouse models of Alzheimer's disease MRI/MRS in neuroinflammation: methodology and applications A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment Microbiota and the control of blood-tissue barriers Adenosine receptor signaling: a key to opening the blood-brain door The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves Cerebrovascular Dysfunction in Preeclamptic Pregnancies Developmental and pathological angiogenesis in the central nervous system The restorative role of annexin A1 at the blood-brain barrier.Intercellular cross-talk in intracerebral hemorrhage Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking Gliomas and the vascular fragility of the blood brain barrier Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Barrier mechanisms in the Drosophila blood-brain barrier The molecular constituents of the blood-brain barrier The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?How Can We Treat Cancer Disease Not Cancer Cells?Immune Regulation of Antibody Access to Neuronal Tissues Novel flow cytometric analysis of the blood-brain barrier Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders Ethical issues in nanomedicine: Tempest in a teapot?Real-time monitoring of human blood-brain barrier disruption Brain Vascular Imaging Techniques Penetrating the Blood-Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles.Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats Focused ultrasound-mediated drug delivery through the blood-brain barrier.Canonical WNT signaling components in vascular development and barrier formation.From cartoon to real time MRI: in vivo monitoring of phagocyte migration in mouse brain Advanced MRI and staging of multiple sclerosis lesions Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control.

P2860

Q21284516-D07219E6-11D6-4A8C-ACEE-84D25D6B7DEA Q22252213-9C925ED8-8D1E-4B8A-8730-B4D5EFF1745B Q26765041-63D5FA9A-7EF9-4F9E-92FF-487FD5AF3BB5 Q26768238-3975339F-C238-4BE2-8AC8-958F15EF0EEC Q26770451-165E03A5-F417-47A1-8054-FA9852FEE71C Q26771883-515CE69E-CC05-44F4-941E-82AEAC4FAC98 Q26771930-2F0359E1-3FEC-4AD7-9F36-DDF478B104BF Q26772837-9DBC5437-A2DD-4286-80B0-E4521A0819A3 Q26776157-DE7076E9-74D0-45DA-9AC3-8A6F155BD3DF Q26785532-A0B0EDDB-428A-4326-AF36-32D99F8C06F3 Q26795435-F714E8E6-20AE-4710-B410-36DC6115E076 Q26795601-055D6DF7-AE1E-4055-8835-D2D5524F8B46 Q26827771-61B41187-CF59-43FA-8425-E311D7C67026 Q26996670-5194F53B-BA0A-455E-945A-0779FC3947B6 Q27023250-AFBEF6B0-32DF-4F80-8B7E-913850842E7F Q27687514-E95474D0-22C8-44D9-AF70-BC9C4FD01E59 Q27692109-517F54FD-9496-478F-842E-A914F9397668 Q28067855-CF17C6C1-A53F-480B-B782-841A132E574B Q28081953-B3C2EFD7-5848-4055-BCE6-281BF0A1C8CE Q28082016-9AE2C6A3-8754-45A1-BA6B-0A85E824A8EC Q28083620-A1E37DA5-2454-4A2D-87BF-157A0AE9DA04 Q28087222-FC2F244C-1A2A-455F-9A87-EB307BB8DEB6 Q28543192-544625AC-06AA-47CC-ADE4-C064BFC155EB Q28546716-00D1DE73-865F-4B0E-9FF2-57EB4ADDAE8A Q28558823-3C3BEA6D-82DD-4B80-969D-EB9C783D768C Q28733365-D81BC055-E991-426A-847C-169EF80E194F Q28833334-E6295AA9-C350-4AC5-99AE-08C25571F3E3 Q29048615-82B3E7D2-8E57-49A0-BBD7-0D0795EC7C88 Q30276129-873DB96A-37D6-4115-AF83-6C06E0AD9F38 Q30359368-69D6B377-4BC2-4A03-AB2E-52951E130BEB Q30363574-4C027513-526A-48D0-B9AE-5E7EE733E0E3 Q30365829-0A4E8937-CE42-4D80-9850-A98B626D6631 Q30392931-0C9D96E0-31DB-4B94-9C57-7A110E6BA4F2 Q30394357-1209DF86-3BB2-4C57-ACB5-AAD73E9FF87B Q30586765-24DB00C0-546B-4378-8CB6-9EF492BAB94A Q30597300-56930434-F298-4BC1-9320-CBE3DA9C7F69 Q30825494-192C289F-C803-4783-8B2C-FDE6DCFDEABB Q30849102-27D4AF70-295D-405C-9649-0B2CB71029AD Q33560284-54F1A9CC-9205-4104-A4D3-F2D441E5D7B6 Q33586092-FF99DAE0-6E16-45BF-B85D-81A145A6066F

P2860

Development, maintenance and disruption of the blood-brain barrier

http://www.wikidata.org/entity/Q26829668

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Development, maintenance and disruption of the blood-brain barrier

@ast

Development, maintenance and disruption of the blood-brain barrier

@en

Development, maintenance and disruption of the blood-brain barrier

@nl

type

label

Development, maintenance and disruption of the blood-brain barrier

@ast

Development, maintenance and disruption of the blood-brain barrier

@en

Development, maintenance and disruption of the blood-brain barrier

@nl

prefLabel

Development, maintenance and disruption of the blood-brain barrier

@ast

Development, maintenance and disruption of the blood-brain barrier

@en

Development, maintenance and disruption of the blood-brain barrier

@nl

P1433

Q26829668-36D5FF45-2E63-4A5F-8BFD-F7E6F6E9B814

P1476

Q26829668-F3280377-9107-4CE8-847D-34427A00F85B

P2093

Q26829668-1332493E-F394-4774-B4AC-3B34C1742E91

Q26829668-F7126AAC-10D5-45C0-BB03-B73D26A428EE

P2860

Q26829668-00124558-6BA3-46D4-A770-45A8673DBB48

Q26829668-01484653-DF6F-46CE-9E12-32C946F81FAF

Q26829668-01D6FFD8-A94D-4F85-9F9E-F151FB836BB0

Q26829668-04198371-30DB-4A68-8849-5F27A428060A

Q26829668-05F5310F-7AC6-4107-9804-78231C2EA9C7

Q26829668-06BBBB40-A9BB-4CC2-944B-AF9A18CEDC60

Q26829668-07626A5E-C9FF-486F-85FA-AC5A90191C27

Q26829668-0CF4E581-A36E-4C94-BE22-E52983EB7F78

Q26829668-0CF4ED86-161A-4208-B445-FB712F108B1E

Q26829668-0E2CEE83-BB79-4404-AA28-000629556540

P2888

Q26829668-EF13CC3D-FD39-4131-BB1F-F558B4C5F73A

P304

Q26829668-48BA410A-524F-40E5-98F5-A7120AD5454C

P31

Q26829668-0FE57BC3-8F03-473A-9580-90FA431CE193

P3181

Q26829668-3A162158-7AC0-4E08-84F9-CC7952AE2A09

P356

Q26829668-0F498ED5-B80C-458B-AFDB-8A1C5458EAFC

P407

Q26829668-7AD55712-5C00-4C25-8765-83769AD0756F

P433

Q26829668-5C446257-5EA0-4EDB-9E02-E23DC94A3D8C

P478

Q26829668-85481628-6ABE-45BD-87DA-E439610AFF72

P50

Q26829668-5C7C19BE-91E8-43E0-9BAA-286CFE4B68BC

P577

Q26829668-540A65B5-397E-4DE6-B1D8-472CC2F3CD72

P6179

Q26829668-AA618ADE-85F0-416E-AA15-F2EEEA287C66

P698

Q26829668-7A5E83FD-97D8-431D-80FD-B6C454C021E4

P921

Q26829668-009D53EB-CDBF-4F38-BD91-17C63B928DEE

Q26829668-2D395860-C367-468C-A440-179C99057CB4

P932

Q26829668-26810AFC-E70D-4DF6-A088-232249F618D2

P3181

P356

P1433

Nature Medicine

P1476

Development, maintenance and disruption of the blood-brain barrier

@en

P2093

Richard Daneman

http://www.w3.org/2001/XMLSchema#string

Richard M Ransohoff

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS

Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging

Pericytes are required for blood-brain barrier integrity during embryogenesis

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

Wnt family proteins are secreted and associated with the cell surface

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development

Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

P2888

P304

1584-1596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

848251

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM.3407

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Birgit Obermeier

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047645755

http://www.w3.org/2001/XMLSchema#string

P698

24309662

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

4080800

http://www.w3.org/2001/XMLSchema#string